Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001682068-26-000003

CHIEF FINANCIAL OFFICER sold 4,739 shares at $16.35 ($77,483)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Regnante Keith CHIEF FINANCIAL OFFICER 2026-02-18 Sale −4,739 $16.35 $77,483 39,261 D
Open-market sales · 4,739 sh · avg $16.35 · $77,483
Loading xslF345X05/form4-02202026_040201.xml…